{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:19:09Z","timestamp":1792455549074,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00417-019-04414-y","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T02:02:44Z","timestamp":1562637764000},"page":"2119-2125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage"],"prefix":"10.1007","volume":"257","author":[{"given":"Reinhard","family":"Angermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rauchegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Nowosielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Casazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Bilgeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1405-7457","authenticated-orcid":false,"given":"Claus","family":"Zehetner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"4414_CR1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227\u20131239. \nhttps:\/\/doi.org\/10.1056\/NEJMra1005073","journal-title":"N Engl J Med"},{"key":"4414_CR2","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"AD Deshpande","year":"2008","unstructured":"Deshpande AD, Harris-Hayes M, Schootman M (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254\u20131264. \nhttps:\/\/doi.org\/10.2522\/ptj.20080020","journal-title":"Phys Ther"},{"key":"4414_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bjophthalmol-2016-309313","volume":"101","author":"C Egan","year":"2017","unstructured":"Egan C, Zhu H, Lee A et al (2017) The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema. Br J Ophthalmol 101:75\u201380. \nhttps:\/\/doi.org\/10.1136\/bjophthalmol-2016-309313","journal-title":"Br J Ophthalmol"},{"key":"4414_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaophthalmol.2018.3578","volume":"136","author":"A Obeid","year":"2018","unstructured":"Obeid A, Gao X, Ali FS et al (2018) Loss to follow-up among patients with neovascular age-related macular degeneration who received intravitreal anti\u2013vascular endothelial growth factor injections. JAMA Ophthalmol 136:1251\u20131259. \nhttps:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3578","journal-title":"JAMA Ophthalmol"},{"key":"4414_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","volume":"125","author":"A Obeid","year":"2018","unstructured":"Obeid A, Gao X, Ali FS et al (2018) Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology 125:1386\u20131392. \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2018.02.034","journal-title":"Ophthalmology"},{"key":"4414_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.survophthal.2012.07.005","volume":"58","author":"AR Elam","year":"2013","unstructured":"Elam AR, Lee PP (2013) High-risk populations for vision loss and eye care underutilization: a review of the literature and ideas on moving forward. Surv Ophthalmol 58:348\u2013358. \nhttps:\/\/doi.org\/10.1016\/j.survophthal.2012.07.005","journal-title":"Surv Ophthalmol"},{"key":"4414_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaophthalmol.2013.1165","volume":"131","author":"Y-J Li","year":"2013","unstructured":"Li Y-J, Xirasagar S, Pumkam C et al (2013) Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol 131:499\u2013506","journal-title":"JAMA Ophthalmol"},{"key":"4414_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09286586.2013.789531","volume":"20","author":"A Paksin-Hall","year":"2013","unstructured":"Paksin-Hall A, Dent ML, Dong F, Ablah E (2013) Factors contributing to diabetes patients not receiving annual dilated eye examinations. Ophthalmic Epidemiol 20:281\u2013287. \nhttps:\/\/doi.org\/10.3109\/09286586.2013.789531","journal-title":"Ophthalmic Epidemiol"},{"key":"4414_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1475-6773.2005.00361.x","volume":"40","author":"KM Nelson","year":"2005","unstructured":"Nelson KM, Chapko MK, Reiber G, Boyko EJ (2005) The association between health insurance coverage and diabetes care; data from the 2000 behavioral risk factor surveillance system. Health Serv Res 40:361\u2013372. \nhttps:\/\/doi.org\/10.1111\/j.1475-6773.2005.00361.x","journal-title":"Health Serv Res"},{"key":"4414_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1471-2458-6-259","volume":"6","author":"CRW Oladele","year":"2006","unstructured":"Oladele CRW, Barnett E (2006) Racial\/ethnic and social class differences in preventive care practices among persons with diabetes. BMC Public Health 6:259. \nhttps:\/\/doi.org\/10.1186\/1471-2458-6-259","journal-title":"BMC Public Health"},{"key":"4414_CR11","unstructured":"World Health Organisation (2016). International statistical classification of diseases and related health problems 10th revision (ICD-10). Visual impairment including blindness (binocular or monocular). \nhttps:\/\/icd.who.int\/browse10\/2016\/en#\/H53-H54\n\n. Accessed 14 Mar 2019"},{"key":"4414_CR12","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"S Sivaprasad","year":"2017","unstructured":"Sivaprasad S, Prevost AT, Vasconcelos JC et al (2017) Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Lancet 389:2193\u20132203. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(17)31193-5","journal-title":"Lancet"},{"key":"4414_CR13","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/jama.2015.15217","volume":"314","author":"JG Gross","year":"2015","unstructured":"Gross JG, Glassman AR, Jampol LM et al (2015) Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA 314:2137\u20132146. \nhttps:\/\/doi.org\/10.1001\/jama.2015.15217","journal-title":"JAMA"},{"key":"4414_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ophtha.2018.07.027","volume":"126","author":"A Obeid","year":"2018","unstructured":"Obeid A, Su D, Patel SN et al (2018) Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 126:407\u2013413. \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2018.07.027","journal-title":"Ophthalmology."},{"key":"4414_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","volume":"62","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Benedict \u00c1, Muszbek N et al (2008) The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 62:76\u201387. \nhttps:\/\/doi.org\/10.1111\/j.1742-1241.2007.01630.x","journal-title":"Int J Clin Pract"},{"key":"4414_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26:331\u2013342","journal-title":"J Clin Pharm Ther"},{"key":"4414_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.critrevonc.2008.01.013","volume":"67","author":"JF Piccirillo","year":"2008","unstructured":"Piccirillo JF, Vlahiotis A, Barrett LB et al (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67:124\u2013132. \nhttps:\/\/doi.org\/10.1016\/j.critrevonc.2008.01.013","journal-title":"Crit Rev Oncol Hematol"},{"key":"4414_CR18","first-page":"2145","volume":"56","author":"J Campbell","year":"2015","unstructured":"Campbell J, Dugel PU, Cole A et al (2015) Comorbidity and healthcare visit burden in elderly diabetic macular edema patients. Invest Ophthalmol Vis Sci 56:2145\u20132145","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4414_CR19","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1097\/IAE.0000000000001892","volume":"38","author":"M Weiss","year":"2018","unstructured":"Weiss M, Sim DA, Herold T et al (2018) Compliance and adherence of patients with diabetic macular edema to intravitreal anti-vascular endothelial growth factor therapy in daily practice. Retina (Philadelphia, Pa) 38:2293\u20132300. \nhttps:\/\/doi.org\/10.1097\/IAE.0000000000001892","journal-title":"Retina (Philadelphia, Pa)"},{"key":"4414_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12955-017-0635-7","volume":"15","author":"X-X Wang","year":"2017","unstructured":"Wang X-X, Lin W-Q, Chen X-J et al (2017) Multimorbidity associated with functional independence among community-dwelling older people: a cross-sectional study in southern China. Health Qual Life Outcomes 15:73. \nhttps:\/\/doi.org\/10.1186\/s12955-017-0635-7","journal-title":"Health Qual Life Outcomes"},{"key":"4414_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jfo.2014.11.015","volume":"38","author":"E Boulanger-Scemama","year":"2015","unstructured":"Boulanger-Scemama E, Querques G, About F et al (2015) Ranibizumab for exudative age-related macular degeneration: a five year study of adherence to follow-up in a real-life setting. J Fr Ophtalmol 38:620\u2013627. \nhttps:\/\/doi.org\/10.1016\/j.jfo.2014.11.015","journal-title":"J Fr Ophtalmol"},{"key":"4414_CR22","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00417-012-2177-3","volume":"251","author":"KM Droege","year":"2013","unstructured":"Droege KM, Muether PS, Hermann MM et al (2013) Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life. Graefes Arch Clin Exp Ophthalmol 251:1281\u20131284. \nhttps:\/\/doi.org\/10.1007\/s00417-012-2177-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4414_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/IAE.0b013e318115169a","volume":"28","author":"JB Saadine","year":"2008","unstructured":"Saadine JB, Fong DS, Yao J (2008) Factors associated with follow-up eye examinations among persons with diabetes. Retina (Philadelphia, Pa) 28:195\u2013200. \nhttps:\/\/doi.org\/10.1097\/IAE.0b013e318115169a","journal-title":"Retina (Philadelphia, Pa)"},{"key":"4414_CR24","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2337\/dc09-0615","volume":"32","author":"TY Wong","year":"2009","unstructured":"Wong TY, Mwamburi M, Klein R et al (2009) Rates of progression in diabetic retinopathy during different time periods. Diabetes Care 32:2307\u20132313. \nhttps:\/\/doi.org\/10.2337\/dc09-0615","journal-title":"Diabetes Care"},{"key":"4414_CR25","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/dc12-0790","volume":"36","author":"K Harris Nwanyanwu","year":"2013","unstructured":"Harris Nwanyanwu K, Talwar N, Gardner TW et al (2013) Predicting development of proliferative diabetic retinopathy. Diabetes Care 36:1562\u20131568. \nhttps:\/\/doi.org\/10.2337\/dc12-0790","journal-title":"Diabetes Care"},{"key":"4414_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5694\/j.1326-5377.2005.tb07085.x","volume":"183","author":"SR Downer","year":"2005","unstructured":"Downer SR, Meara JG, Da Costa AC (2005) Use of SMS text messaging to improve outpatient attendance. Med J Aust 183:366\u2013368","journal-title":"Med J Aust"},{"key":"4414_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11845-008-0192-5","volume":"177","author":"E Dervan","year":"2008","unstructured":"Dervan E, Lillis D, Flynn L et al (2008) Factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 177:303. \nhttps:\/\/doi.org\/10.1007\/s11845-008-0192-5","journal-title":"Ir J Med Sci"},{"key":"4414_CR28","doi-asserted-by":"publisher","first-page":"e019989","DOI":"10.1136\/bmjopen-2017-019989","volume":"8","author":"J Lian","year":"2018","unstructured":"Lian J, McGhee SM, Gangwani RA et al (2018) Awareness of diabetic retinopathy and its association with attendance for systematic screening at the public primary care setting: a cross-sectional study in Hong Kong. BMJ Open 8:e019989. \nhttps:\/\/doi.org\/10.1136\/bmjopen-2017-019989","journal-title":"BMJ Open"},{"key":"4414_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1046\/j.1464-5491.2002.00784.x","volume":"19","author":"M Trento","year":"2002","unstructured":"Trento M, Bajardi M, Borgo E et al (2002) Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabet Med 19:810\u2013813","journal-title":"Diabet Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04414-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04414-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04414-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:34:16Z","timestamp":1594164856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04414-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4414"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04414-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The approval for retrospective studies is waived by the institutional review board of the Medical University Innsbruck, Innsbruck, Austria. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}